This Is MS Multiple Sclerosis Knowledge & Support Community

Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental new drug application (sNDA) for three-times-a-week Copaxone 40mg/mL, a new dose of Copaxone . This new formulation will allow for a less frequent dosing regimen administered subcutaneously for patients with relapsing forms of multiple sclerosis (MS). In addition to the newly approved dose, daily Copaxone 20 mg/mL will continue to be available. The daily subcutaneous injection was approved in 1996......... Read More - http://www.ms-uk.org/copaxone

Interesting. I've been using copaxone now for over 15 years, and have NO interest in moving to an every-other-day regimen.

I manage taking my own perscriptions and can't imagine how I would keep track of taking a shot every other day. Poor memory makes simple things like this quit difficult.

I'm sure I'm not alone in that respect.

Anyone know what the price will be for the three times a week prescription? Will insurance companies cover this new drug?

I will be glad to switch to this if my insurance will pay. It's very likely that it will be more expensive than the every day shots, because it's new on the market.